Advancing Cell Therapy Development with Integrated Analytical and Process Strategies, Upcoming Webinar Hosted by Xtalks

In this free webinar, explore approaches to developing and implementing proliferation, AAV/mRNA potency, cell killing and flow cytometry assays in cell therapy development. Attendees will learn how analytical and process development (PD/AD) workflows can rapidly generate “fit-for-purpose ” testing to support small-scale PD work on accelerated timelines. The featured speakers will discuss how emerging technologies are being applied in cell therapy PD/AD.

TORONTO, Oct. 27, 2025 /PRNewswire/ — Analytical and process development (PD/AD) strategies directly impact how quickly and reliably cell therapies reach patients. Join this webinar to explore integrated PD/AD expertise that delivers robust, regulatory-ready assays and accelerates cell therapy development.

The featured speakers will share case studies on rapid potency assay creation for AAV and mRNA products, along with additional optimized and transferable solutions.

Attendees will join a live poll on PD/AD challenges, with results discussed in real time.

The session will showcase standalone analytical services, including potency assay development, flow cytometry modules and cell therapy assay platforms.

Register for this webinar to learn how integrated PD/AD strategies can accelerate cell therapy development through regulatory-ready assays.

Join experts from Kincell Bio, Patrick Kellish, PhD, Senior Scientist, Analytical Development; and Douglas Mogensen, VP, Commercial Development, for the live webinar on Tuesday, November 11, 2025, at 11am EST (5pm CET/EU-Central).

For more information, or to register for this event, visit Advancing Cell Therapy Development with Integrated Analytical and Process Strategies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/advancing-cell-therapy-development-with-integrated-analytical-and-process-strategies-upcoming-webinar-hosted-by-xtalks-302594097.html

SOURCE Xtalks

Staff

Recent Posts

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…

4 hours ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the…

13 hours ago

Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support

LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- This holiday season, addiction experts at Desert Hope…

13 hours ago

Profound Medical Corp. Announces Upsize of Private Placement

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the…

13 hours ago

ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal…

13 hours ago